CureSureMedico
Currency

Aplastic Anemia Treatment

Hematology

payments

Starting from

$15,000

Up to $90,000 depending on centre

schedule

Typical duration

45–100 days

Including pre-operative work-up

medical_services

Procedures

3

Hold to see procedures

arrow_downwardlocal_hospital

Partner hospitals

0

Vetted for outcome data & accreditation

Overview

Receive potentially curative treatment for severe aplastic anemia through bone marrow transplantation or highly effective immunosuppressive therapy (IST) with anti-thymocyte globulin and cyclosporine. India and Israel offer world-class aplastic anemia programs with experienced hematologists at costs 60–80% below those in Western countries.

Your case is matched to a centre on the basis of clinical outcome data, not marketing. We coordinate every step — from pre-operative work-up to post-treatment follow-up — with a dedicated care coordinator.

What's included

Specialist hematology consultation and bone marrow biopsy
HLA typing and donor search coordination
BMT procedure or full IST course with monitoring
Isolation room, transfusion support, and infection prophylaxis
Patient coordinator, interpreter, and visa support guidance
Detailed discharge plan with protocol for home-country follow-up

Coordinated from

$15,000

or message us on WhatsApp

No commitment required. Your data is never shared with third parties.

Global cost comparison — Aplastic Anemia Treatment

Average coordinated costs across our partner centres. Final pricing depends on clinical complexity and chosen hospital.

CountryAvg. cost
🇮🇳

India

New Delhi · Chennai · Bengaluru · Hyderabad · Mumbai · Kochi

Best value
$18,000
🇹🇷

Turkey

Istanbul

$75,000

Costs are indicative and reviewed quarterly. Request a personalised estimate for your specific case.

Frequently asked questions

The choice depends primarily on age, disease severity, and donor availability. For patients under 40 with severe or very severe aplastic anemia who have a matched sibling donor, bone marrow transplant is the preferred curative option with long-term success rates above 85%. For older patients, those without a matched donor, or those with non-severe disease, immunosuppressive therapy with horse-ATG or rabbit-ATG plus cyclosporine is the standard first-line approach, achieving responses in 60–70% of patients. Our partner hematologists will review your CBC, bone marrow biopsy, and HLA typing to provide a tailored recommendation before you travel.

No fees. No commitment.

Our guidance is completely free

We are compensated by our partner hospitals — never by patients. You get independent clinical matching, cost transparency, and end-to-end coordination at no cost to you.

Message us on WhatsApp